Nuntius Therapeutics
Cell-specific genetic medicines
London, United Kingdom · Founded 2021
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2021
- Website
- nuntiustx.com
- Last Round
- Pre-SeedJan 2021
- Rounds
- 1
About
Cell-specific genetic medicines
Summary
Nuntius Therapeutics is a Biotech company based in London, United Kingdom, founded in 2021. Its most recent funding was a Pre-Seed round in Jan 2021. Investors include Asymmetry Ventures, Backed and FoundersX Ventures.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2021
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nuntius-therapeutics"><img src="https://indexed.vc/api/badge/company/nuntius-therapeutics" alt="Nuntius Therapeutics on Indexed.vc" width="260" height="76" /></a>